Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic respiratory infections.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002675:Child, Preschool; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000628:therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000276:immunology* / Q000472:pathogenicity; D012141:Respiratory Tract Infections / Q000628:therapy*; D012703:Serotyping; D014774:Virulence
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines